Pill Connect Limited

Pill Connect Limited

Private
ManchesterHealthcare & Life Scienceshttps://www.pillconnect.com/

Last Round

VC Round

Feb 13, 2025

Total Funding Raised

$670,000

Company Overview

Pill Connect Limited is a medical devices company that has developed a patented smart pill dispenser and cloud analytics platform for use in clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Health IoT, Medical Devices, Healthcare Analytics, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medication adherencesmart pill dispenserclinical trial technologyadherence monitoringsmart capCRO technologyremote patient monitoringRPMIoMTconnected drug deliveryhealthcare analyticsdosing datadecentralized clinical trialsHealth IoTmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pill Connect Limited Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pill Connect Limited Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 13, 2025
Early FundingOct 21, 2022
SeedNov 3, 2020
Series ASep 19, 2017

Key People

Founding team and executive leadership

James Burnstone

Chief Executive Officer

Executive Team

Richard Smith

Chief Financial Officer

Executive Team

Pill Connect Limited Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2025

    Secured funding from GMC Life Sciences Fund and NPIF II.

  • Nov 10, 2024

    Monthly visitors increased 169% MoM.

Pill Connect Limited Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pill Connect Limited Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pill Connect Limited's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester
Employee Range6
Year Founded2013
Last FundingFeb 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.